Tick-borne Rickettsiosis is an infection caused by the Rickettsia bacteria. Tick-borne rickettsiosis is transmitted to humans after they are bitten by infected ticks. Symptoms of tick-borne rickettsiosis appear 5-14 days after infection and can include headache, fever, nausea, and skin rash around the tick-bite. Treatment of tick-borne rickettsiosis includes use of medications such as doxycycline, rifampin, chloramphenicol, and azithromycin, but a doctor should be consulted before considering these. There is no available vaccine to prevent tick-borne rickettsiosis, but the disease can be prevented by minimizing exposure to ticks and by wearing protective clothing and using tick repellents.
Tick-borne Rickettsiosis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Tick-borne Rickettsiosis below!
For more information on how to use Laverne, please read the How to Guide.
We have 884 products for the study of Tick-borne Rickettsiosis that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.